Skip to main content

GTS SECURITIES LLC

Broker-Dealer

Position in GILD — Gilead Sciences, Inc.

CIK 1452765 NEW YORK, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$582,174
-$404,147 QoQ
Shares Held
4,608
-34.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,311
of 2,266 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Sep 30, 2024
CallValue
$6,170,624
CallShares
73,600
PutValue
$5,835,264
PutShares
69,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

GTS SECURITIES LLC holds $12,976,736 across 10 Drug Manufacturers - General names. GILD ranks #9 (4.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GILD

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $582,174 4,608
2026-03-31 $986,321 7,077
2025-12-31 $1,740,575 14,181
2025-09-30 $2,833,386 25,526
2025-06-30 $719,324 6,488
2025-03-31 $730,902 6,523
2024-12-31 $1,281,818 13,877
2024-09-30 $6,170,624 73,600
2024-09-30 $5,835,264 69,600
2024-09-30 $8,105,986 96,684
2024-06-30 $4,885,032 71,200
2024-06-30 $5,708,352 83,200
2024-06-30 $5,512,813 80,350
2024-03-31 $6,760,975 92,300
2024-03-31 $2,651,650 36,200
2024-03-31 $2,298,218 31,375
2023-12-31 $5,962,336 73,600
2023-12-31 $7,623,041 94,100
2023-12-31 $1,966,355 24,273
2023-09-30 $8,333,328 111,200
2023-09-30 $8,507,713 113,527
2023-09-30 $8,483,208 113,200
2023-06-30 $7,547,156 97,926